Zealand Pharma Announces Financial Results for the First Quarter of 2023
11 mai 2023 01h00 HE
|
Zealand Pharma
Company announcement - No. 20 / 2023 Zealand Pharma Announces Financial Results for the First Quarter of 2023 Positive topline data from obesity portfolioOn track for two regulatory submissions...
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
10 mai 2023 02h30 HE
|
Zealand Pharma
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight Phase II dose-finding trial met primary endpoint after 46...
Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results
04 mai 2023 11h05 HE
|
Zealand Pharma
Press Release– No. 3 / 2023 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results Copenhagen, Denmark, May 4, 2023 – a Zealand Pharma A/S...
Total number of shares and voting rights in Zealand Pharma at April 28, 2023
28 avr. 2023 11h05 HE
|
Zealand Pharma
Company announcement – No. 18 / 2023 Total number of shares and voting rights in Zealand Pharma at April 28, 2023 Copenhagen, Denmark, April 28, 2023 – Zealand Pharma A/S (“Zealand”)...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
25 avr. 2023 13h30 HE
|
Zealand Pharma
Company announcement – No. 17 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
19 avr. 2023 16h00 HE
|
Zealand Pharma
Company announcement – No. 16 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023
19 avr. 2023 15h45 HE
|
Zealand Pharma
Company announcement – No. 15 / 2023 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 Copenhagen, Denmark,...
Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference
12 avr. 2023 11h00 HE
|
Zealand Pharma
Press release – No. 2 / 2023 Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference Copenhagen, Denmark, April 12, 2023 – Zealand Pharma A/S (Nasdaq...
Zealand Pharma completes registration of capital increase
04 avr. 2023 02h32 HE
|
Zealand Pharma
Company announcement – No. 14 / 2023 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES,...
Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen
03 avr. 2023 03h29 HE
|
Zealand Pharma
Company announcement – No. 13 / 2023 Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen NOT FOR...